Marlborough medical technology firm Boston Scientific ... currents to interrupt pain signals traveling to the brain, opening the door to effective pain management without the use of opioids.

The company will compete with a device Boston Scientific acquired for $850 million.

But when Eddy was recruited to join medical-device maker Boston Scientific in 2013, she “had a vision that we could transform ...

Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Type of Neurostimulation Device ...

Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market - A Global and Regional Analysis: Focus on Type, Application, End User, and Country - Analysis and Forecast ...

and pain management. Boston Scientific is renowned for its cutting-edge technologies, such as stents, pacemakers, and endoscopic tools, which enhance patient care and improve clinical outcomes.

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.

Boston Scientific Corporation ... BSX is under-leveraged in pain treatment, and I think this is an area that could use some extra management attention to rectify. Lastly, I do have some concerns ...